Clinical Biomarkers of World Trade Center Airway Hyperreactivity: A 16-Year Longitudinal Study
-
2019/04/01
-
Details
-
Personal Author:
-
Description:PURPOSE: Particulate matter exposure and metabolic syndrome (MetSyn) are known risk factors of airway hyperreactivity (AHR) and lung dysfunction. We investigate clinical biomarkers including those defining MetSyn as predictors of World Trade Center(WTC)-AHR in the Fire Department of New York World Trade Center(WTC)-exposed cohort. METHODS: A cohort of male firefighters with FEV1 ≥LLN pre-9/11 that had serum drawn before site closure on July 24, 2002(N=7,486) was assessed, Figure 1. Cases of WTC-AHR(N=539) were identified if they had either a positive bronchodilator response or had a positive methacholine challenge(N=355). WTC-AHR were compared to N=6947 non-WTC-AHR. We modeled the ability of MetSyn at the first post-9/11 exam to predict WTC-AHR with Cox regression and adjusted for age and smoking status. We additionally examined leukocyte subsets as a comparison of a commonly associated marker of airway hyperreactivity. RESULTS: WTC-AHR cases were older(40 vs 39), had higher BMI(29 vs 28 kg/m2), high intensity exposure(23% vs 16%), and more likely to have MetSyn compared to controls (20% vs 2%). There was a significant exposure dose response; the most highly exposed present in the morning of 9/11 had 2.24-fold increased risk of developing WTC-AHR. Having MetSyn increased risk of WTC-AHR by 65.4%(p<0.001). Having at least 5% eosinophilia on first post-9/11 differential independently increased the risk of WTC-AHR by 83.8%(p<0.001). Smoking history was not a significant risk factor in development of WTC-AHR. CONCLUSIONS: Dyslipidemia, insulin resistance, and CVD biomarkers suggest that systemic inflammation can contribute to future airway hyperreactivity. CLINICAL IMPLICATIONS: Further investigations assessing the impact of reversible MetSyn factors in AHR are needed. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0012-3692
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:155
-
Issue:4
-
NIOSHTIC Number:nn:20066281
-
Citation:Chest 2019 Apr; 155(4)(Suppl):142A
-
Federal Fiscal Year:2019
-
Performing Organization:New York University School of Medicine
-
Peer Reviewed:False
-
Start Date:20170701
-
Source Full Name:Chest
-
End Date:20260630
-
Collection(s):
-
Main Document Checksum:urn:sha-512:e8f4c066129d32507b332233dea90d1f87ec0c0125abdb22e333dc51be4ca409ec242ab4280bd91cfc435c115926d6413058cc03d3b1c2998fa26f748a993979
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like